Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today ...

Alterome Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of next-generation, small molecule targeted therapies for the treatment of cancer, today announced ...

Dr. Howard Zucker, who as a top official of the Centers for Disease Control and the World Health Organization, and New York State Health Commissioner, rigorously applied data to ensure that billions ...